LOADING
Prostate cancer is one of the most impactful diagnoses a veteran can face, and the VA provides a clear compensation pathway through both presumptive service connection and specific rating criteria. For Vietnam-era veterans exposed to Agent Orange, prostate cancer has long been a presumptive condition. Under the PACT Act and expanded presumptive frameworks, this coverage extends to additional veteran populations. Understanding how active cancer ratings, post-treatment re-evaluations, and residual ratings work is essential for affected veterans and their families.
Prostate cancer is rated under Diagnostic Code 7528 within 38 CFR 4.115b. The initial rating for active malignant neoplasms of the genitourinary system is 100 percent. This rating continues for six months following the cessation of surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. After that six-month period, the VA conducts a mandatory re-examination to evaluate the residuals of the cancer and its treatment.
Following the re-examination, if there is no local recurrence or metastasis, the rating is based on the residuals of the cancer and treatment. Residuals typically include urinary incontinence, voiding dysfunction, urinary frequency, erectile dysfunction, and sometimes bowel dysfunction from radiation treatment. Each residual is rated under its applicable diagnostic code within the genitourinary schedule.
Voiding dysfunction is rated based on the specific type of dysfunction and its severity. Urine leakage requiring the wearing of absorbent materials is rated at 20, 40, or 60 percent depending on frequency of change. Urinary frequency is rated at 10, 20, or 40 percent based on the daytime voiding interval and nighttime awakenings. Obstructed voiding is rated based on symptoms like slow stream, straining, and urinary retention.
Erectile dysfunction following prostate cancer treatment is extremely common, as the nerves responsible for erection run along the prostate and are often affected by surgery or radiation. This residual supports SMC-K for loss of use of a creative organ, in addition to any schedular rating under DC 7522. The 100 percent active cancer rating during treatment does not preclude the SMC-K award, because SMC-K is paid on top of the schedular rating.
Prostate cancer has long been recognized as a presumptive condition for veterans exposed to Agent Orange. Under 38 CFR 3.309(e), veterans who served in the Republic of Vietnam, certain Thailand bases, Korean DMZ during specified periods, or other covered locations during specified periods are presumed to have been exposed to Agent Orange. A diagnosis of prostate cancer combined with this qualifying service establishes service connection automatically, without a nexus requirement.
The PACT Act expanded the list of covered locations for Agent Orange presumptive exposure. Blue Water Navy veterans who served in the waters offshore Vietnam, veterans who served in Thailand at various bases, and veterans who served at certain installations where herbicides were stored or transported all now qualify. Veterans previously denied prostate cancer claims based on pre-PACT Act rules should consider filing supplemental claims.
Evidence for a prostate cancer claim includes medical records confirming the diagnosis, pathology reports, treatment records including surgery, radiation, and chemotherapy, records of ongoing monitoring such as PSA tests, DD-214 and deployment records to establish qualifying service for presumptive exposure, and records of all residual conditions that developed during or after treatment.
For the six-month post-treatment re-examination, prepare by documenting every residual. Keep a log of urinary symptoms including frequency, urgency, leakage, and pad use. Document erectile function status. Note any bowel symptoms if radiation was used. Bring medications and products like absorbent pads to the exam. The residual ratings can be substantial if documented well, particularly for urinary incontinence requiring frequent pad changes.
A reduction from 100 percent to a lower residual rating can be challenged if the residuals are in fact severe. Under 38 CFR 3.344, ratings that have been in effect for five years or more are considered stabilized and cannot be reduced without showing sustained material improvement under ordinary conditions of life. For recent ratings, the re-examination determines the ongoing rating, but the veteran retains the right to appeal if the residual rating does not accurately reflect the condition.
Recurrence or metastasis restarts the 100 percent rating. If prostate cancer returns or spreads, the veteran returns to 100 percent for the duration of active treatment plus the six-month post-treatment period. Any rating reduction that occurs after this cycle is again subject to re-examination.
Survivor benefits should be considered for veterans with prostate cancer. If a veteran dies of prostate cancer that was presumptively service-connected, the surviving spouse may be eligible for Dependency and Indemnity Compensation (DIC) under 38 USC 1310. DIC is a substantial ongoing benefit that many surviving spouses do not realize they qualify for.
The Claim Recon Rating Calculator models how the 100 percent active cancer rating combines with any other service-connected conditions, and how the transition to residual ratings may affect your combined disability picture. The C&P Exam Simulator prepares you for the post-treatment re-examination, including the genitourinary DBQ questions that drive residual ratings. The Secondary Condition Finder maps prostate cancer to the urinary and sexual dysfunction residuals commonly developing from treatment. The Personal Statement Builder helps you document residual symptoms in the framework used for genitourinary ratings.
Disclaimer: This article is for educational and informational purposes only. It does not constitute legal, medical, or VA claims advice. Cancer rating criteria under 38 CFR 4.115b and Agent Orange presumptive provisions are subject to change. Always verify current criteria at VA.gov or consult with an accredited VSO, attorney, or claims agent before making decisions about your benefits.
Written by Claim Recon Editorial